文献速递主动脉疾病颈动脉与弓上血管

异常锁骨下动脉相关主动脉夹层的中期结局:单中心回顾性观察研究

Midterm Outcome of Aortic Dissection Associated With Aberrant Subclavian Artery: A Single-Center Retrospective Observational Study.
PubMed 文献 · J Endovasc Ther · 2024-12-30

该单中心回顾性观察研究纳入2011至2021年间48例接受外科干预的异常锁骨下动脉(aSA)合并主动脉夹层患者,报告早期与中期结局。30天死亡率为12.5%,总体死亡率为20.8%,中位随访4.5年。在Stanford B型及非A非B型夹层亚组中,开放手术组与微创组30天死亡率无统计学显著差异(18.3% vs 8.3%,p=0.815)。

要点

  • aSA合并主动脉夹层患者手术干预结局较差,总体死亡率为20.8%。
  • 中位随访4.5年,1、3、5、7年Kaplan-Meier生存率分别为87.0%、82.5%、79.7%、75.1%。
  • B型及非A非B型夹层中开放手术与微创组30天死亡率无显著差异(18.3% vs 8.3%,p=0.815)。

核心结论

  • 对aSA合并主动脉夹层患者行外科干预结局较差。
  • 作者认为,对于aSA合并Kommerell憩室(KD)的患者,可考虑早期干预以预防主动脉夹层的发生。

研究设计与样本

  • 单中心回顾性观察研究,2011至2021年间共纳入48例接受外科干预的aSA合并主动脉夹层患者。
  • 手术干预方式包括开放手术、杂交手术和腔内治疗。
  • 其中Stanford A型夹层20例(41.7%),Stanford B型夹层9例(18.8%),非A非B型夹层19例(39.6%)。
  • 对Stanford B型及非A非B型夹层患者进行手术及术后情况的亚组分析。

主要发现

  • 患者平均年龄48.81±9.65岁。
  • 30天死亡率为12.5%,总体死亡率为20.8%,中位随访时间4.5年(四分位距[IQR]:2-8.75年)。
  • 中枢神经系统并发症8例(16.7%),锁骨下动脉窃血综合征6例(12.5%),呼吸系统并发症3例(6.2%)。
  • 术后1年、3年、5年和7年的估计Kaplan-Meier生存率分别为87.0%、82.5%、79.7%和75.1%。
  • 在Stanford B型及非A非B型夹层患者中,开放手术组与微创组30天死亡率无统计学显著差异(18.3% vs 8.3%,p=0.815)。

临床怎么用

  • 作者认为,对于aSA合并KD的患者,可考虑早期干预以预防主动脉夹层的发生。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aberrant subclavian artery (aSA) is a rare anomaly of the aortic branches. Approximately 20-60% of patients with an aSA are associated with Kommerell's diverticulum (KD). These vascular anomalies have been reported to increase the risk of aortic rupture (4-19%) and aortic dissection. However, limited studies have investigated the treatment of aortic dissection in patients with aSA and KD. This study aims to investigate clinical characteristics and midterm follow-up outcomes of patients with aortic dissection associated with aSA. MATERIALS AND METHODS: Between 2011 and 2021, a total of 48 patients with aSA anomalies underwent aortic dissection surgical intervention. Surgical interventions include open surgery, hybrid surgery, and endovascular therapy. Among them, 20 (41.7%) had Stanford type A dissection, 9 (18.8%) had Stanford type B dissection, and 19 (39.6%) had non-A non-B dissection. We report the early and midterm clinical outcomes including mortality, central nervous system complication and respiratory complication, and other operative outcomes including reintervention rates and endoleak. A subgroup analysis of the surgical and postoperative conditions was performed on Stanford type B and non-A non-B aortic dissection patients. RESULTS: The mean age of the patient population was 48.81±9.65 years. The 30-day mortality rate was 12.5%. The overall mortality rate was 20.8%, with a median follow-up time of 4.5 years (interquartile range [IQR]: 2-8.75 years). Central nervous system complications occurred in 8 patients (16.7%), subclavian steal syndrome in 6 patients (12.5%), and respiratory complications in 3 patients (6.2%). The estimated Kaplan-Meier survival rates at 1 year, 3 years, 5 years, and 7 years after surgery were, respectively, 87.0%, 82.5%, 79.7%, and 75.1%. For Stanford type B and non-A non-B aortic dissection patients, the 30-day mortality rate between the open surgery group and the minimally invasive group had no statistically significant differences (18.3% vs 8.3%, p=0.815). CONCLUSIONS: Surgical intervention for aSA patients with aortic dissection has poor outcomes. Early intervention might be considered for patients with aSA and KD to prevent the occurrence of aortic dissection.Clinical ImpactAberrant subclavian artery (aSA) and Kommerell's diverticulum (KD) have been reported to increase the risk of aortic rupture and aortic dissection. This study is currently the largest single-center retrospective study on aSA combined with aortic dissection, providing standardized data reporting and midterm follow-up of patients with this rare vascular anomaly.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Sun Y, Gu Y, Dong S, et al. Midterm Outcome of Aortic Dissection Associated With Aberrant Subclavian Artery: A Single-Center Retrospective Observational Study. J Endovasc Ther. 2024. PMID: 40165434. doi:10.1177/15266028241307568

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。